1. 3PC-026 What is the best chemical decontamination solution for conventional anti-neoplastic drugs in a hospital compounding unit?. (March 2019) Authors: Simon, N; Odou, P; Decaudin, B; Bonnabry, P; Fleury-Souverain, S Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4CPS-241 DDI-predictor: a novel clinical pharmacy decision-making tool for dose adaptation?. (March 2019) Authors: Moreau, F; Simon, N; Tod, M; Decaudin, B; Odou, P Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 969 Intra-Abdominal Rectal Perforation Post Haemorrhoidal Artery Ligation Operation (HALO) And Converted Ligasure Open Haemorrhoidectomy. (12th October 2021) Authors: Simon, N; Saiyara, N; Gercek, Y Journal: British journal of surgery Issue: Volume 108:Supplement 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. B159 The effect of propofol on ropivacaine-induced central nervous system toxicity in pigs. (11th August 2022) Authors: Rupnik, B; Diemunsch, P; Simon, N; Chauvin, C; Le Gourrier, L; Schaffler, A; Aguirre, J; Borgeat, A Journal: Regional anesthesia and pain medicine Issue: Volume 47(2022)Supplement 1 Page Start: A163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O26 Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young Infants. Issue 6 (17th May 2019) Authors: Jacqz-Aigrain, E; Leroux, S; Thomson, AH; Allegaert, K; Capparelli, EV; Biran, V; Simon, N; Meibohm, B; Y-L, Lo; Marqués, R; Peris, J-E; Lutsar, I; Saito, J; Nayamura, H; van den Anker, JN; Sharland, M; Zhao, W Journal: Archives of disease in childhood Issue: Volume 104:Issue 6(2019) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OHP-013 Assessment of medical devices intended to administer antineoplastic drugs compounded in syringes: methodology proposal. (25th February 2017) Authors: Lefebvre, M; Simon, N; Vasseur, M; Sidikou, O; Barthélémy, C; Décaudin, B; Odou, P Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OHP-017 Ability of infusion devices to deliver the expected volume of antineoplastic drug in solution: an in vitro assessment. (24th March 2015) Authors: Lebecque, M; Simon, N; Legrand, JF; Pinturaud, M; Vasseur, M; Barthélémy, C; Décaudin, B; Odou, P Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OHP-025 Combined effect of a closed system transfer device and decontamination in the reduction of occupational exposure in compounding unit. (25th February 2017) Authors: Vasseur, M; Simon, N; Pincon, C; Pinturaud, M; Soichot, M; Richeval, C; Bonnabry, P; Allorge, D; Décaudin, B; Odou, P Journal: European journal of hospital pharmacy Issue: Volume 24(2017)Supplement 1 Page Start: A189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P01.034 Prospective evaluation of alternative therapies in glioma patients in France. (19th September 2018) Authors: Le Rhun, E; Lebrun Frenay, C; Devos, P; Darlix, A; Lorgis, V; Ahle, G; Boone, M; Taillandier, L; Curtit, E; Gras, L; Bourg, V; Ramirez, C; Reyns, N; Weller, M; Simon, N Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P148 JAK-inhibition by baricitinib and tofacitinib ameliorates pathological bone loss. (March 2019) Authors: Adam, S; Simon, N; Steffen, U; Andes, F; Müller, D; Culemann, S; Andreev, D; Hahn, M; Scholtysek, C; Schett, G; Krönke, G; Frey, S; Hueber, A Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗